FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4207009910> ?p ?o ?g. }

• W4207009910 endingPage "i366" @default.
• W4207009910 startingPage "i366" @default.
• W4207009910 abstract "Abstract Background The use of immunosuppressive medications such as thiopurines and methotrexate (MET) are commonly employed in inflammatory bowel disease (IBD) to control symptoms and maintain remission. The British Society of Gastroenterology recommends three monthly full blood count (FBC) and liver function tests (LFT) to monitor for myelotoxicity and hepatotoxicity after being established on therapy. However, the quality of evidence for this is low. Due to the high burden of blood tests and patients becoming increasingly apprehensive to attend hospital or their general practice surgery in the midst of a pandemic, we aimed to investigate (1) the feasibility to adhere to these recommendations and (2) the frequency of abnormal blood test when recommendations are adhered. Methods We performed a, 12-month cross sectional study from July, 2017 to July, 2018 of patients established on azathioprine (AZA), 6-mercaptopurine (6-MP), or MET. The timeline was split into four windows of three months each. A patient was removed from the study if they reached any one of these six end points: no FBC or LFT checked within a window, new abnormal LFT, white cell count (WCC) less than, 3.5, change in medication, change in dosage, and medication stopped. Results As of, 2019, 4327 patients were under the care of our specialist IBD team with, 1081 on active therapy. We identified, 205 patients who were established on these agents (AZA = 156, 6-MP = 41, MET = 8) within the determined study period. A total number of, 96 patients reached an end point during this period. For our first objective, a patient was deemed to have been monitored if FBC and LFT was checked at least once during a window., 26% (54/212) of patients were removed from the study as they did not fulfil this criteria. Of the remaining, 41 patients who reached an end point, 14 were due to a new abnormal LFT result (AZA = 8, 6-MP = 6, MET = 0) and, 5 due to a WCC less than, 3.5 (AZA = 4, 6-MP = 1, MET =0). Excluding non-adherent patients, our study revealed only, 12% (19/158) of patients had to discontinue therapy due to an abnormal blood test. Conclusion Achieving an adherence of, 74% was possible with a team of dedicated IBD specialist nurses and doctors in a tertiary centre. Whilst there is still much room for improvement, this may be difficult to replicate in smaller centres with more limited resources. Despite the small sample size, our finding of only, 12% of abnormal blood test is consistent with similar studies done by Fournier et.al in, 2010 and Chaparro et.al in, 2013. This would certainly pose the question if we can consider monitoring less frequently." @default.
• W4207009910 created "2022-01-26" @default.
• W4207009910 creator A5003068786 @default.
• W4207009910 creator A5003449281 @default.
• W4207009910 creator A5041732733 @default.
• W4207009910 creator A5050719368 @default.
• W4207009910 creator A5060297063 @default.
• W4207009910 creator A5062156434 @default.
• W4207009910 creator A5083540168 @default.
• W4207009910 date "2022-01-01" @default.
• W4207009910 modified "2023-09-27" @default.
• W4207009910 title "P357 Monitoring of Thiopurines and Methotrexate in Inflammatory Bowel Disease: Are we Monitoring Too Frequently? A Cross Sectional Study" @default.
• W4207009910 doi "https://doi.org/10.1093/ecco-jcc/jjab232.484" @default.
• W4207009910 hasPublicationYear "2022" @default.
• W4207009910 type Work @default.
• W4207009910 citedByCount "0" @default.
• W4207009910 crossrefType "journal-article" @default.
• W4207009910 hasAuthorship W4207009910A5003068786 @default.
• W4207009910 hasAuthorship W4207009910A5003449281 @default.
• W4207009910 hasAuthorship W4207009910A5041732733 @default.
• W4207009910 hasAuthorship W4207009910A5050719368 @default.
• W4207009910 hasAuthorship W4207009910A5060297063 @default.
• W4207009910 hasAuthorship W4207009910A5062156434 @default.
• W4207009910 hasAuthorship W4207009910A5083540168 @default.
• W4207009910 hasBestOaLocation W42070099101 @default.
• W4207009910 hasConcept C126322002 @default.
• W4207009910 hasConcept C142052008 @default.
• W4207009910 hasConcept C142724271 @default.
• W4207009910 hasConcept C2776760755 @default.
• W4207009910 hasConcept C2777173762 @default.
• W4207009910 hasConcept C2778260677 @default.
• W4207009910 hasConcept C2779134260 @default.
• W4207009910 hasConcept C2780479503 @default.
• W4207009910 hasConcept C2781059491 @default.
• W4207009910 hasConcept C512861765 @default.
• W4207009910 hasConcept C70917649 @default.
• W4207009910 hasConcept C71924100 @default.
• W4207009910 hasConcept C90924648 @default.
• W4207009910 hasConceptScore W4207009910C126322002 @default.
• W4207009910 hasConceptScore W4207009910C142052008 @default.
• W4207009910 hasConceptScore W4207009910C142724271 @default.
• W4207009910 hasConceptScore W4207009910C2776760755 @default.
• W4207009910 hasConceptScore W4207009910C2777173762 @default.
• W4207009910 hasConceptScore W4207009910C2778260677 @default.
• W4207009910 hasConceptScore W4207009910C2779134260 @default.
• W4207009910 hasConceptScore W4207009910C2780479503 @default.
• W4207009910 hasConceptScore W4207009910C2781059491 @default.
• W4207009910 hasConceptScore W4207009910C512861765 @default.
• W4207009910 hasConceptScore W4207009910C70917649 @default.
• W4207009910 hasConceptScore W4207009910C71924100 @default.
• W4207009910 hasConceptScore W4207009910C90924648 @default.
• W4207009910 hasIssue "Supplement_1" @default.
• W4207009910 hasLocation W42070099101 @default.
• W4207009910 hasOpenAccess W4207009910 @default.
• W4207009910 hasPrimaryLocation W42070099101 @default.
• W4207009910 hasRelatedWork W1992761307 @default.
• W4207009910 hasRelatedWork W199653422 @default.
• W4207009910 hasRelatedWork W2081201360 @default.
• W4207009910 hasRelatedWork W2089392787 @default.
• W4207009910 hasRelatedWork W2334467272 @default.
• W4207009910 hasRelatedWork W2405193817 @default.
• W4207009910 hasRelatedWork W2417042754 @default.
• W4207009910 hasRelatedWork W2531543608 @default.
• W4207009910 hasRelatedWork W3087427934 @default.
• W4207009910 hasRelatedWork W73433536 @default.
• W4207009910 hasVolume "16" @default.
• W4207009910 isParatext "false" @default.
• W4207009910 isRetracted "false" @default.
• W4207009910 workType "article" @default.